Patents Assigned to Eagle Vision Pharmaceutical Corporation
  • Manganese compositions and methods for MRI
    Patent number: 5980863
    Abstract: An MRI contrast medium of improved safety and efficacy is disclosed. The composition includes a source of calcium ions and a source of manganese ions in a ratio of from 2:1 to 40:1 in a vehicle suitable for parenteral administration. A method of enhancing an MRI signal in a mammalian tissue with the foregoing composition is also provided.
    Type: Grant
    Filed: November 2, 1998
    Date of Patent: November 9, 1999
    Assignee: Eagle Vision Pharmaceutical Corporation
    Inventors: Phillip P. Harnish, Peter R. Seoane, Adele R. Vessey